Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zolpidem for Sleep in Children With Autism
NCT05540574Phase 2Recruiting
- Sponsor
- Stanford University
- Start
- Aug 2023
- Primary completion
- Apr 2028
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of zolpidem sublingual tablet in sleep disorder (2 arms), sponsored by Stanford University. Primary endpoint: Change from baseline in sleep architecture at Week 8. Started Aug 2023; status: recruiting.
02
Drugs
zolpidem sublingual tablet
03
Conditions
sleep disorder
Beyond the preview
Go deeper on NCT05540574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05540574.